Effectiveness of a pharmacy-led personalised intervention program aimed at improving adherence to oral diabetes and/or hypertension medication in people with type 2 diabetes
Authors:
- Marlous Langendoen-GortMLMarlous Langendoen-Gort
- Sharon RemmelzwaalSRSharon Remmelzwaal
- Femke RuttersFRFemke Rutters
- Hiyam Al-JabrHAHiyam Al-Jabr
- Maartje de WitMWMaartje de Wit
- Debi BhattacharyaDBDebi Bhattacharya
- Jacqueline G HugtenburgJHJacqueline G Hugtenburg
- Andrew FarmerAFAndrew Farmer
- Petra Jm EldersPEPetra Jm Elders
Preprint
Abstract
Aims/hypothesis: To evaluate the effectiveness of a personalised intervention program aimed at improving medication adherence in people with type 2 diabetes who are non-adherent to oral diabetes and/or hypertension medication, compared to usual care including access to a diabetes website, after a six-month follow-up. Methods: Parallel-group randomised controlled trial with six-month follow-up conducted in community pharmacies in the Netherlands and United Kingdom. People with type 2 diabetes, 35-75 years and non-adherent to oral diabetes and/or hypertension medication were recruited. The intervention group received the personalised intervention program and the control group received usual care and an informative diabetes website. The primary outcome was medication adherence measured by telephone pill count and secondary outcomes were self-reported medication adherence, systolic blood pressure and HbA1c level. Linear regression analysis and longitudinal mixed model analysis were performed to assess intervention effectiveness. Results: The study population comprised 68 participants, 66.2% men with a median age of 65.0 [Q1 to Q3 59.3 to 71.0] years. Linear regression analysis for the primary outcome medication adherence showed no significant effect of the intervention (B −0.014, 95% CI −0.17 to 0.14). In addition, no significant differences were found between the intervention and control group for self-reported medication adherence (OR 3.18, 95% CI 0.89 to 11.37) and systolic blood pressure (B −1.41, 95% CI −9.64 to 6.83). Finally, the intervention group did not show better HbA1c levels compared to the control group (B 0.68, 95% CI 0.44 to 0.92). Conclusions/interpretation: We did not observe a statistically significant difference, nor a clinically point estimate of difference, in medication adherence between the intervention and control group of a personalised intervention program aimed at improving medication adherence in people with type 2 diabetes who are non-adherent to oral diabetes and/or hypertension medication after six-months follow-up. We therefore do not recommend implementation of the intervention program in daily practice. Trial registry number: Registered in the Dutch Trial Register (Trial NL8747) and ISRCTN Registry ( ISRCTN36009809 ). Social media post: No effect of a personalised intervention program was observed on medication adherence in people with type 2 diabetes. Future studies should first focus on alternative recruitment methods for non-adherent people with type 2 diabetes, before the effectiveness of the intervention can be re-evaluated in a larger study sample. Research in context: What is already known about this subject?: Medication non-adherence is a common health problem in people with type 2 diabetes. Most medication adherence interventions showed small and inconsistent effects, potentially because interventions are not personalised to the needs of participants. What is the key question?: What is the effect of a personalised intervention program aimed at improving medication adherence in people with type 2 diabetes who are non-adherent to oral diabetes and/or hypertension medication, compared to usual care including access to a publicly available diabetes website, after six months of follow-up? What are the new findings?: No effect was observed of the personalised intervention program on medication adherence measured with a telephone pill count. No effect was observed of the personalised intervention program on self-reported medication adherence and systolic blood pressure. The intervention group did not show better HbA1c levels compared to the control group. Recruitment of participants was challenging and as such we were unable to achieve the intended study sample. How might this impact on clinical practice in the foreseeable future?: We currently do not recommend implementation of the personalised intervention program in routine practice. Further work is first needed to establish alternative recruitment methods for non-adherent people with type 2 diabetes, before the effectiveness of the intervention can be re-evaluated in a larger study sample.Keywords
Funding Information
- EFSD award supported by Servier
This publication has 11 references indexed in Scilit:
- What is the effect of mobile phone text message reminders on medication adherence among adult type 2 diabetes mellitus patients: a systematic review and meta-analysis of randomized controlled trialsBMC Endocrine Disorders, 2023
- Validation of an Announced Telephone Pill Count Compared to a Home‐Visit Pill Count in People With Type 2 Diabetes or Cardiovascular DiseaseClinical Pharmacology in Drug Development, 2022
- A personalised intervention programme aimed at improving adherence to oral antidiabetic and/or antihypertensive medication in people with type 2 diabetes mellitus, the INTENSE study: study protocol for a randomised controlled trialTrials, 2022
- Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: A systematic literature reviewDiabetes, Obesity and Metabolism, 2021
- The Medication Adherence Report Scale: A measurement tool for eliciting patients' reports of nonadherenceBritish Journal of Clinical Pharmacology, 2019
- Implementation fidelity of an intervention programme to enhance adherence to antihypertensive medication in Dutch community pharmaciesInternational Journal of Clinical Pharmacy, 2019
- Effectiveness of a Patient-Tailored, Pharmacist-Led Intervention Program to Enhance Adherence to Antihypertensive Medication: The CATI StudyFrontiers in Pharmacology, 2018
- The (cost-)effectiveness of a patient-tailored intervention programme to enhance adherence to antihypertensive medication in community pharmacies: study protocol of a randomised controlled trialTrials, 2017
- A Systematic Review of Interventions Addressing Adherence to Anti-Diabetic Medications in Patients with Type 2 Diabetes—Components of InterventionsPLOS ONE, 2015
- Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventionsPatient Preference and Adherence, 2013